Clinical Trials Browser

Completed × Carcinoma, Transitional Cell × Everolimus × Clear all

NCT00805129 2022-11-25

Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium

Phase 2 Completed

46 enrolled 11 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00714025 2012-01-24

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Phase 2 Completed

NOG-Related-Symphalangism Spectrum Disorder, Carcinoma, Transitional Cell